Roots Analysis has done a detailed study on Patient Recruitment and Retention Services Market, 2019-2030, covering key aspects of the industry’s evolution and identifying potential future growth opportunities.
To order this 300+ page report, which features 90+ figures and 140+ tables, please visit this link
Key Market Insights
- Presently, close to 140 companies claim to be actively engaged in offering patient recruitment / retention services to the pharmaceutical and medical devices industries, employing a variety of outreach methods and solutions
- The market landscape is fragmented and distributed across various geographies; the growing need for specialized / niche study populations and cost saving options have made offshoring a popular trend
- Majority of the services providers are based in developed regions; the market is characterized by the presence of both established players and small-sized companies / new entrants
- Companies involved in this domain are steadily expanding their capabilities in order to enhance their respective service portfolios and comply to evolving industry benchmarks
- The growing trend of outsourcing patient-recruitment-related activities is evident from the rise in partnership activity in the recent past and from the opinions expressed by eminent stakeholders in the industry
- Several growth opportunities, driven by increasing volume of clinical trials, exist; some of these focus specially on the development of therapies for rare and complex indications
- We expect the patient recruitment market for the services providers to increase steadily and grow by over 5% in the coming years
For more information, please visit https://www.rootsanalysis.com/reports/view_document/patient-recruitment-and-retention-services-market-2019-2030/245.html
Table of Contents
- PREFACE
1.1. Scope of the Report
1.2. Research Methodology
1.3. Chapter Outlines
2. EXECUTIVE SUMMARY
3. PATIENT RECRUITMENT AND RETENTION IN CLINICAL TRIALS
3.1. Chapter Overview
3.2. Clinical Trials
3.2.1. Clinical Trial Phases
3.3. Patient Recruitment
3.3.1. The Patient Recruitment Process
3.3.2. Challenges Associated with Patient Recruitment
3.3.3. Strategies to Improve Patient Recruitment
3.3.4. Ethical Considerations
3.4. Outsourcing of Patient Recruitment
3.4.1. Patient Recruitment Services
3.5. Patient Retention
3.5.1. Patient Retention Services
4. PATIENT OUTREACH METHODS
4.1. Chapter Overview
4.2. Patient Outreach Methods
4.2.1. Traditional Media
4.2.1.1. Physician Referrals
4.2.1.2. Television
4.2.1.3. Radio
4.2.1.4. Print Media (Newspaper, Flyers, Brochures and Posters)
4.2.1.5. Direct Mail Campaigns
4.2.1.6. Cold Call / Call Center
4.2.1.7. Advantages and Limitations of Traditional Media
4.2.2. Emerging / Novel Methods
4.2.2.1. Social Media
4.2.2.1.1. Social Media Platforms Used in Patient Recruitment
4.2.2.1.1.1. Geo-Social Media
4.2.2.1.1.2. Social Networking Websites
4.2.2.1.2. Advantages and Limitations of Social Media
4.2.2.2. Mobile / Software Applications
4.2.2.3. Patient Networks
4.2.2.4. Patient Advocacy Groups
4.2.2.5. Electronic Medical Records (EMRs) / Electronic Health Records (EHRs) and Other Health Data
4.2.2.6. Promotion of Trials in Indication Specific Events for Patients
4.2.3. Best Practices / Recommendations for Patient Outreach
5. COMPETITIVE MARKET LANDSCAPE OF PATIENT RECRUITMENT AND RETENTION
SERVICE PROVIDERS
5.1. Chapter Overview
5.2. Patient Recruitment and Retention Service Providers: Overall Market Landscape
5.2.1. Analysis by Year of Establishment
5.2.2. Analysis by Company Size
5.2.3. Analysis by Geography
5.2.4. Analysis by Patient Recruitment and Retention Services Offered
5.2.5. Analysis by Patient Outreach Methods
5.2.6. Analysis by Patient Recruitment Associated Services
5.2.7. Analysis by Patient Retention Methods
5.2.8. Analysis by Geographical Reach
5.2.9. Analysis by Therapeutic Expertise
5.2.10. Information on Payment Model, Recruitment Technology / Platform, and Regulatory Approval /
Certification / Compliance Status
6. COMPANY COMPETITIVENESS ANALYSIS
6.1. Chapter Overview
6.2. Methodology
6.3. Assumptions and Key Parameters
6.4. Patient Recruitment and Retention Service Providers: Company Competitiveness Analysis
6.4.1. Small-Sized Companies
6.4.2. Mid-Sized Companies
6.4.3. Large Companies
7. COMPANY PROFILES
7.1. Chapter Overview
7.2. Patient Recruitment Service Providers in North America
7.2.1. Acurian
7.2.1.1. Company Overview
7.2.1.2. Financial Information
7.2.1.3. Patient Recruitment and Retention Services
7.2.1.4. Recent Developments
7.2.1.5. Future Outlook
7.2.2. BBK Worldwide
7.2.2.1. Company Overview
7.2.2.2. Financial Information
7.2.2.3. Patient Recruitment and Retention Services
7.2.2.4. Recent Developments
7.2.2.5. Future Outlook
7.2.3. Bright Pharmaceuticals Services
7.2.3.1. Company Overview
7.2.3.2. Patient Recruitment and Retention Services
7.2.3.3. Future Outlook
7.2.4. ClinEdge
7.2.4.1. Company Overview
7.2.4.2. Patient Recruitment and Retention Services
7.2.4.3. Recent Developments
7.2.4.4. Future Outlook
7.2.5. CSSi
7.2.5.1. Company Overview
7.2.5.2. Patient Recruitment and Retention Services
7.2.5.3. Recent Developments
7.2.5.4. Future Outlook
7.2.6. CTM
7.2.6.1. Company Overview
7.2.6.2. Patient Recruitment and Retention Services
7.2.6.2 Future Outlook
7.2.7. Integrated Clinical Trial Services (ICTS)
7.2.7.1. Company Overview
7.2.7.2. Patient Recruitment and Retention Services
7.2.7.3. Recent Developments
7.2.7.4. Future Outlook
7.2.8. MMG
7.2.8.1. Company Overview
7.2.8.2. Patient Recruitment and Retention Services
7.2.8.3. Future Outlook
7.2.9. Topstone Research
7.2.9.1. Company Overview
7.2.9.2. Patient Recruitment and Retention Services
7.2.9.3. Future Outlook
7.2.10. WCCT Global
7.2.10.1. Company Overview
7.2.10.2. Financial Information
7.2.10.3. Patient Recruitment Services
7.2.10.4. Recent Developments
7.2.10.5. Future Outlook
7.3. Patient Recruitment Service Providers in Europe
7.3.1. Antidote
7.3.1.1. Company Overview
7.3.1.2. Financial Information
7.3.1.3. Patient Recruitment and Retention Services
7.3.1.4. Recent Developments
7.3.1.5. Future Outlook
7.3.2. FIDELIS RESEARCH
7.3.2.1. Company Overview
7.3.2.2. Financial Information
7.3.2.3. Patient Recruitment and Retention Services
7.3.2.4. Recent Developments
7.3.2.5. Future Outlook
7.3.3. Ignite Data
7.3.3.1. Company Overview
7.3.3.2. Financial Information
7.3.3.3. Patient Recruitment and Retention Services
7.3.3.4. Future Outlook
7.3.4. Polaris BioPharma Consulting
7.3.4.1. Company Overview
7.3.4.2. Patient Recruitment and Retention Services
7.3.4.3. Recent Developments
7.3.5. Tudor Reilly Health
7.3.5.1. Company Overview
7.3.5.2. Financial Information
7.3.5.3. Patient Recruitment and Retention Services
7.3.5.4. Recent Developments
7.3.5.5. Future Outlook
7.4. Patient Recruitment Services Providers in Asia Pacific
7.4.1. CROèe
7.4.1.1. Company Overview
7.4.1.2. Patient Recruitment and Retention Services
7.4.1.3. Recent Developments
7.4.1.4. Future Outlook
7.4.2. Jsure Healthmedia
7.4.2.1. Company Overview
7.4.2.2. Patient Recruitment and Retention Services
7.4.2.3. Future Outlook
7.4.3. TrialWire
7.4.3.1. Company Overview
7.4.3.2. Patient Recruitment and Retention Services
7.4.3.3. Recent Developments
7.4.4. Pacific Groove
7.4.4.1. Company Overview
7.4.4.2. Patient Recruitment and Retention Services
7.4.4.3. Recent Developments
7.4.4.4. Future Outlook
8. PARTNERSHIPS AND COLLABORATIONS
8.1. Chapter Overview
8.2. Partnership Models
8.3. Patient Recruitment and Retention Services: List of Partnerships and Collaborations
8.3.1. Analysis by Year of Partnerships
8.3.2. Analysis by Type of Partnership
8.3.3. Analysis by Purpose of Agreement
8.3.4. Analysis by Therapeutic Area
8.3.5. Most Active Players: Analysis by Number of Partnerships
8.3.6. Geographical Analysis
8.3.6.1. Intercontinental and Intracontinental Agreements
9. RECENT TRENDS IN PATIENT RECRUITMENT AND RETENTION
9.1. Chapter Overview
9.1.1. Social Media-based Campaigning to Accelerate Patient Recruitment in Clinical Trials
9.1.2. Adoption of Mobile Technologies for Patient Recruitment and Retention
9.1.3. Use of EHR Data to Improve Patient Recruitment Rates
9.1.4. Other Real-World Data Sources to Help Overcome Patient Recruitment-Related Challenges
9.1.5. Growing Focus on Conducting Clinical Research in Emerging Markets
10. FUTURE GROWTH OPPORTUNITIES
10.1. Chapter Overview
10.1.1. Anticipated Increase in the Number of Global Clinical Trials
10.1.2. Growing Demand for Orphan Drugs and Personalized Medicine
10.1.3. Increased Offshoring of Clinical Development Operations to Emerging Regions
10.1.4. Availability of Service Providers Offering One-Stop-Solutions
10.1.5. Stringent Regulations and Complex Study Protocols Expected to Promote Outsourcing
11. MARKET SIZING AND OPPORTUNITY ANALYSIS
11.1. Chapter Overview
11.2. Forecast Methodology and Key Assumptions
11.3. Overall Patient Recruitment Services Market, 2019-2030
11.4. Patient Recruitment Services Market: Distribution by Therapeutic Area, 2019-2030
11.5. Patient Recruitment Services Market: Distribution by Steps in Patient Recruitment Process, 2019-
2030
11.6. Patient Recruitment Services Market: Distribution by Phase of Development, 2019-2030
11.7. Patient Recruitment Services Market: Distribution by Geography, 2019-2030
11.7.1. Patient Recruitment Services Market: Market Attractiveness Analysis by Country, 2019-2030
11.7.2. Patient Recruitment Services Market in North America, 2019-2030
11.7.2.1. Patient Recruitment Services Market in the US: Distribution by Phase of Development, 2019-
2030
11.7.2.2. Patient Recruitment Services Market in the US: Distribution by Therapeutic Area, 2019-2030
11.7.2.3. Patient Recruitment Services Market in Canada: Distribution by Phase of Development, 2019-2030
11.7.2.4. Patient Recruitment Services Market in Canada: Distribution by Therapeutic Area, 2019-2030
11.7.3. Patient Recruitment Services Market in EU5, 2019-2030
11.7.3.1. Patient Recruitment Services Market in Germany: Distribution by Phase of Development, 2019-2030
11.7.3.2. Patient Recruitment Services Market in Germany: Distribution by Therapeutic Area, 2019-2030
11.7.3.3. Patient Recruitment Services Market in France: Distribution by Phase of Development, 2019-2030
11.7.3.4. Patient Recruitment Services Market in France: Distribution by Therapeutic Area, 2019-2030
11.7.3.5. Patient Recruitment Services Market in the UK: Distribution by Phase of Development, 2019-2030
11.7.3.6. Patient Recruitment Services Market in the UK: Distribution by Therapeutic Area, 2019-2030
11.7.3.7. Patient Recruitment Services Market in Italy: Distribution by Phase of Development, 2019-2030
11.7.3.8. Patient Recruitment Services Market in Italy: Distribution by Therapeutic Area, 2019-2030
11.7.3.9. Patient Recruitment Services Market in Spain: Distribution by Phase of Development, 2019-2030
11.7.3.10. Patient Recruitment Services Market in Spain: Distribution by Therapeutic Area, 2019-2030
11.7.4. Patient Recruitment Services Market in Asia Pacific, 2019-2030
11.7.4.1. Patient Recruitment Services Market in Japan: Distribution by Phase of Development, 2019-2030
11.7.4.2. Patient Recruitment Services Market in Japan: Distribution by Therapeutic Area, 2019-2030
11.7.4.3. Patient Recruitment Services Market in South Korea: Distribution by Phase of Development, 2019-2030
11.7.4.4. Patient Recruitment Services Market in South Korea: Distribution by Therapeutic Area, 2019-2030
11.7.4.5. Patient Recruitment Services Market in Australia: Distribution by Phase of Development, 2019-2030
11.7.4.6. Patient Recruitment Services Market in Australia: Distribution by Therapeutic Area, 2019-2030
11.7.4.7. Patient Recruitment Services Market in China: Distribution by Phase of Development, 2019-2030
11.7.4.8. Patient Recruitment Services Market in China: Distribution by Therapeutic Area, 2019-2030
11.7.4.9. Patient Recruitment Services Market in India: Distribution by Phase of Development, 2019-2030
11.7.4.10. Patient Recruitment Services Market in India: Distribution by Therapeutic Area, 2019-2030
11.7.5. Patient Recruitment Services Market in Rest of the World, 2019-2030
11.7.5.1. Patient Recruitment Services Market in Rest of the World: Distribution by Phase of Development, 2019-2030
11.7.5.2. Patient Recruitment Services Market in Rest of the World: Distribution by Therapeutic Area, 2019-2030
12. CONCLUSION
12.1. Evolving Requirements Related to Patient Enrolment have Imposed a Significant Burden on Drug Developers, Causing Many to Outsource their Recruitment and Retention-related Processes
12.2. Several CROs Offer Patient Recruitment and Retention Services across the Globe; North America and Europe have Emerged as Key Hubs
12.3. Currently, a Variety of Outreach Methods are being used to Enroll Patient from Across Different Geographies and Therapeutic Areas
12.4. Innovation, Use of Real World Evidence and the Establishment of Strategic Alliances between Stakeholders are Anticipated to Act as Key Market Enablers
12.5. Driven by the Increasing Demand for Niche and Highly Specific Patient Populations in Clinical Trials, the Patient Recruitment Services Market is Anticipated to Witness Significant Growth in the Coming Decade
13. INTERVIEW TRANSCRIPTS
13.1. Chapter Overview
13.2. Link2Trials
13.2.1. Interview Transcript: Simon Klaasen, Co-founder and Managing Director
13.3. nRollmed
13.3.1. Interview Transcript: Hagit Nof, Chief Operation Officer and Business Development Officer
13.4. Seeker Health
13.4.1. Interview Transcript: Paul Ivsin, Managing Director
14. APPENDIX 1: TABULATED DATA
15. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS
Contact Details
Gaurav Chaudhary
+1 (415) 800 3415
Therefore, the use of technology can save time and money, while providing a far better understanding of the relationships between different formulations and processes parameters.Key Drivers, Restraints, and Opportunities of AI in Pharma and Biotech MarketAdoption of artificial intelligence (AI) in the drug discovery market in developing regions such as APAC is increasing, thanks to the expansion of pharmaceutical industries by collaborating with other industries and rise in demand to reduce drug discovery time.
Furthermore, the expansion of biotechnology industries is estimated to offer significant opportunities for the market.An estimated 50% of U.S. citizens are affected by at least one chronic condition; consequently, the pharmaceutical segment of the healthcare industry is projected to be positively impacted by the expected trend of AI adoption.All top 10 so-called giant pharma companies (namely Novartis, Roche, Pfizer, Merck, AstraZeneca, GlaxoSmithKline, Sanofi, Abbvie, Bristol-Myers Squibb, and Johnson & Johnson) have either expressly collaborated with or acquired AI technologies to take advantage of the opportunities AI brings to the table.
Industry leaders are presently focused on the development of more efficient methods, and machine learning is emerging as a possible solution.The current machine learning initiatives of the top five pharmaceutical and biotechnology companies reveal trends within the following areas:Digital coaching solutions – Utilization of web-based technologies to simulate one-on-one coaching sessions so that all patients can have the benefit of a uniquely devised medication program.For instance: Johnson & Johnson’s Patient Athlete programPersonalized medicine – Personalized medicine, also called precision medicine, maybe a medical model that separates people into different groups—with medical decisions, practices, interventions, and/or products being tailored to the individual patient supported their predicted response or risk of disease.For instance.
Unlike other applications within healthcare facilities, drug discovery seems to own a clearer path to adoption.Recently, robots became more collaborative with humans and are more easily trained by moving them through the desired task.
Over time, it seems likely that an equivalent improvement in intelligence that we have seen in other areas of AI would be incorporated into physical robots.Surgical robots initially approved in the U.S. in 2000, provided ‘superpowers’ to surgeons, improving their ability to examine, create precise and minimally invasive incisions, and stitch wounds.
Common surgical procedures using robotic surgery include gynecologic surgery, prostate surgery, and head and neck surgery.Pre Book Ai In Pharma And Biotech Market Report – https://www.transparencymarketresearch.com/checkout.php?rep_id=79399=S North America to Capture Major Share of Global Market of AI in Pharma & BiotechNorth America is expected to account for a major share of the global market of AI in Pharma and Biotech due to the high prevalence of chronic diseases among the population.
Softcon Systems brings you automation solutions specific to the pharmaceutical industry – we will work with you to develop and implement ideal solutions specific to your requirements.
Automation at every point of the value chain will enable the pharma companies to get pharmaceuticals from the lab to the patient more quickly.We design systems that help pharmaceutical and biotech companies to achieve operational excellence, reduce time to market and meet all industry standards and regulations.
